Human T-lymphotropic virus subtype b (HTLV-2b) infection has been described among aborigines from Northern Argentina, while HTLV-2a has been described in an injecting drug user (IDU) from a Central region, similar to the situation in Spain, the United States, and Brazil. In this study, 22 of the 26 strains analyzed from blood donors and HIV-1+ individuals were HTLV-2b (84.6%) clustering with Amerindian references, while 4 HIV-1+ (15.4%) were HTLV-2a. HTLV-2a sequences were closely related to Brazilian references in contrast to the previous Argentinean IDU strain that clustered with Africans and Amerindians from North America. In summary, these findings show that HTLV-2b is the major strain circulating in an urban population of Argentina. HTLV-2a/b could have been introduced from endemic South American countries such as Brazil and because of contact with other populations such as IDUs from Europe despite its introduction due to the increasing internal migration of aborigines to large urban centers. Considering this results and recent data about the dissemination of HTLV-1 in residents of Buenos Aires city, new studies among non-at-risk groups for HTLV-1/2 infection should be performed.
Get full access to this article
View all access options for this article.
References
1.
SwitzerWM, SalemiM, QariSH, JiaH, GrayRR, KatzourakisA, MarriottSJ, PryorKN, WolfeND, BurkeDS, FolksTM, HeneineW. Ancient, independent evolution and distinct molecular features of the novel human T-lymphotropic virus type 4. Retrovirology, 2009; 6:9.
2.
KalyanaramanVS, SarngadharanMG, Robert-GuroffM, MiyoshiI, GoldeD, GalloRC. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science, 1982; 218:571–573.
3.
PoieszBJ, RuscettiFW, GazdarAF, BunnPA, MinnaJD, GalloRC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA, 1980; 77:7415–7419.
4.
GessainA, BarinF, VernantJC, GoutO, MaursL, CalenderA, de TheG. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet, 1985; 2:407–410.
5.
BiglioneMM, PizarroM, SalomonHE, BerriaMI. A possible case of myelopathy/tropical spastic paraparesis in an Argentinian woman with human T lymphocyte virus type II. Clin Infect Dis, 2003; 37:456–458.
6.
ModahlLE, YoungKC, VarneyKF, Khayam-BashiH, MurphyEL. Are HTLV-II-seropositive injection drug users at increased risk of bacterial pneumonia, abscess, and lymphadenopathy?J Acquir Immune Defic Syndr Hum Retrovirol, 1997; 16:169–175.
7.
MurphyEL, FrideyJ, SmithJW, EngstromJ, SacherRA, MillerK, GibbleJ, StevensJ, ThomsonR, HansmaD, KaplanJ, KhabbazR, NemoG. HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II-infected blood donors. The REDS investigators. Neurology, 1997; 48:315–320.
8.
SilvaEA, OtsukiK, LeiteAC, AlamyAH, Sa-CarvalhoD, VicenteAC. HTLV-II infection associated with a chronic neurodegenerative disease: clinical and molecular analysis. J Med Virol, 2002; 66:253–7.
9.
FerrerJF, EstebanE, DubeS, BasombrioMA, SegoviaA, Peralta-RamosM, DubeDK, SayreK, AguayoN, HengstJ, PoieszBJ. Endemic infection with human T cell leukemia/lymphoma virus type IIB in Argentinean and Paraguayan Indians: epidemiology and molecular characterization. J Infect Dis, 1996; 174:944–953.
10.
IshakR, VallinotoAC, AzevedoVN, LewisM, HallWW, Guimaraes IshakMO. Molecular evidence of mother-to-child transmission of HTLV-IIc in the Kararao Village (Kayapo) in the Amazon region of Brazil. Rev Soc Bras Med Trop, 2001; 34:519–525.
11.
LalRB, Gongora-BiachiRA, PardiD, SwitzerWM, GoldmanI, LalAF. Evidence for mother-to-child transmission of human T lymphotropic virus type II. J Infect Dis, 1993; 168:586–591.
12.
LowisGW, SheremataWA, MinagarA. Epidemiologic features of HTLV-II: Serologic and molecular evidence. Ann Epidemiol, 2002; 12:46–66.
13.
BiglioneM, GessainA, QuiruelasS, FayO, TabordaMA, FernandezE, LupoS, PanzitaA, de TheG. Endemic HTLV-II infection among Tobas and Matacos Amerindians from north Argentina. J Acquir Immune Defic Syndr, 1993; 6:631–633.
14.
BlackFL, BiggarRJ, NeelJV, MaloneyEM, WatersDJ. Endemic transmission of HTLV type II among Kayapo Indians of Brazil. AIDS Res Hum Retroviruses, 1994; 10:1165–1171.
15.
de TheG, BomfordR. An HTLV-I vaccine: why, how, for whom?AIDS Res Hum Retroviruses, 1993; 9:381–386.
16.
Echeverria de PerezG, Leon-PonteM, NoyaO, BottoC, GalloD, BiancoN. First description of endemic HTLV-II infection among Venezuelan Amerindians. J Acquir Immune Defic Syndr, 1993; 6:1368–1372.
17.
FerrerJF, Del PinoN, EstebanE, ShermanMP, DubeS, DubeDK, BasombrioMA, PimentelE, SegoviaA, QuirulasSet al.High rate of infection with the human T-cell leukemia retrovirus type II in four Indian populations of Argentina. Virology, 1993; 197:576–584.
18.
HjelleB, WilsonC, CyrusS, BradshawP, LoJ, SchammelC, WiltbankT, AlexanderS. Human T-cell leukemia virus type II infection frequently goes undetected in contemporary US blood donors. Blood, 1993; 81:1641–1644.
19.
LairmoreMD, JacobsonS, GraciaF, DeBK, CastilloL, LarreateguiM, RobertsBD, LevinePH, BlattnerWA, KaplanJE. Isolation of human T-cell lymphotropic virus type 2 from Guaymi Indians in Panama. Proc Natl Acad Sci USA, 1990; 87:8840–8844.
20.
LevinePH, JacobsonS, ElliottR, CavalleroA, ColcloughG, DorryC, StephensonC, KniggeRM, DrummondJ, NishimuraMet al.HTLV-II infection in Florida Indians. AIDS Res Hum Retroviruses, 1993; 9:123–127.
21.
MaloneyEM, BiggarRJ, NeelJV, TaylorME, HahnBH, ShawGM, BlattnerWA. Endemic human T cell lymphotropic virus type II infection among isolated Brazilian Amerindians. J Infect Dis, 1992; 166:100–107.
22.
VrielinkH, ReesinkHW. HTLV-I/II prevalence in different geographic locations. Transfus Med Rev, 2004; 18:46–57.
23.
SlatteryJP, FranchiniG, GessainA. Genomic evolution, patterns of global dissemination, and interspecies transmission of human and simian T-cell leukemia/lymphotropic viruses. Genome Res, 1999; 9:525–540.
24.
EirakuN, NovoaP, da Costa FerreiraM, MonkenC, IshakR, da Costa FerreiraO, ZhuSW, LorencoR, IshakM, AzvedoV, GuerreiroJ, de OliveiraMP, LoureiroP, HammerschlakN, IjichiS, HallWM. Identification and characterization of a new and distinct molecular subtype of human T-cell lymphotropic virus type 2. J Virol, 1996; 70:1481–1492.
25.
HallWW, TakahashiH, LiuC, KaplanMH, ScheewindO, IjichiS, NagashimaK, GalloRC. Multiple isolates and characteristics of human T-cell leukemia virus type II. J Virol, 1992; 66:2456–2463.
26.
VandammeAM, SalemiM, Van BrusselM, LiuHF, Van LaethemK, Van RanstM, MichelsL, DesmyterJ, GoubauP. African origin of human T-lymphotropic virus type 2 (HTLV-2) supported by a potential new HTLV-2d subtype in Congolese Bambuti Efe Pygmies. J Virol, 1998; 72:4327–4340.
27.
The HTLV European Research Network. Seroepidemiology of the human T-cell leukaemia/lymphoma viruses in Europe. J Acquir Immune Defic Syndr Hum Retrovirol, 1996; 13:68–77.
28.
AlcantaraLC, ShindoN, Van DoorenS, SalemiM, CostaMC, KashimaS, CovasDT, VandammeAM, Galvao-CastroB. Brazilian HTLV type 2a strains from intravenous drug users (IDUs) appear to have originated from two sources: Brazilian Amerindians and European/North American IDUs. AIDS Res Hum Retroviruses, 2003; 19:519–523.
29.
MurphyEL, MahieuxR, de TheG, TekaiaF, AmetiD, HortonJ, GessainA. Molecular epidemiology of HTLV-II among United States blood donors and intravenous drug users: an age-cohort effect for HTLV-II RFLP type aO. Virology, 1998; 242:425–434.
30.
SalemiM, Van DoorenS, AudenaertE, DelaporteE, GoubauP, DesmyterJ, VandammeAM. Two new human T-lymphotropic virus type I phylogenetic subtypes in seroindeterminates, a Mbuti pygmy and a Gabonese, have closest relatives among African STLV-I strains. Virology, 1998; 246:277–287.
31.
SwitzerWM, BlackFL, PieniazekD, BiggarRJ, LalRB, HeneineW. Endemicity and phylogeny of the human T cell lymphotropic virus type II subtype A from the Kayapo Indians of Brazil: evidence for limited regional dissemination. AIDS Res Hum Retroviruses, 1996; 12:635–640.
32.
SwitzerWM, PieniazekD, SwansonP, SamdalHH, SorianoV, KhabbazRF, KaplanJE, LalRB, HeneineW. Phylogenetic relationship and geographic distribution of multiple human T-cell lymphotropic virus type II subtypes. J Virol, 1995; 69:621–632.
33.
DubeS, LoveJL, DubeDK, Leon-PonteM, de PerezGE, BarojaML, BiancoN, PoieszBJ. The complete genomic sequence of an HTLV-II isolate from a Guahibo Indian from Venezuela. Virology, 1999; 253:181–192.
34.
Duenas-BarajasE, BernalJE, VaughtDR, BricenoI, DuranC, YanagiharaR, GajdusekDC. Coexistence of human T-lymphotropic virus types I and II among the Wayuu Indians from the Guajira Region of Colombia. AIDS Res Hum Retroviruses, 1992; 8:1851–1855.
35.
ShindoN, AlcantaraLC, Van DoorenS, SalemiM, CostaMC, KashimaS, CovasDT, TevaA, PellegriniM, BritoI, VandammeAM, Galvao-CastroB. Human retroviruses (HIV and HTLV) in Brazilian Indians: Seroepidemiological study and molecular epidemiology of HTLV type 2 isolates. AIDS Res Hum Retroviruses, 2002; 18:71–77.
36.
ZaninovicV, GalindoJ, BlankA. Enfermedades asociadas con el virus HTLV-1. Fundación Mar: Cali, Colombia, 1992.
37.
SalemiM, CattaneoE, CasoliC, BertazzoniU. Identification of IIa and IIb molecular subtypes of human T-cell lymphotropic virus type II among Italian injecting drug users. J Acquir Immune Defic Syndr Hum Retrovirol, 1995; 8:516–520.
38.
ZellaD, CavicchiniA, SalemiM, CasoliC, LoriF, AchilliG, CattaneoE, LandiniV, BertazzoniU. Molecular characterization of two isolates of human T cell leukaemia virus type II from Italian drug abusers and comparison of genome structure with other isolates. J Gen Virol, 1993; 74,Pt 3:437–444.
39.
IshakR, VallinotoAC, AzevedoVN, Ishak MdeO. Epidemiological aspects of retrovirus (HTLV) infection among Indian populations in the Amazon Region of Brazil. Cad Saude Publica, 2003; 19:901–914.
40.
VallinotoAC, IshakMO, AzevedoVN, VicenteAC, OtsukiK, HallWW, IshakR. Molecular epidemiology of human T-lymphotropic virus type II infection in Amerindian and urban populations of the Amazon region of Brazil. Hum Biol, 2002; 74:633–644.
41.
CovasDT, KashimaS. Complete nucleotide sequences of the genomes of two Brazilian specimens of human T lymphotropic virus type 2 (HTLV-2)AIDS Res Hum Retroviruses, 2003; 19:689–697.
42.
LewisMJ, NovoaP, IshakR, IshakM, SalemiM, VandammeAM, KaplanMH, HallWW. Isolation, cloning, and complete nucleotide sequence of a phenotypically distinct Brazilian isolate of human T-lymphotropic virus type II (HTLV-II)Virology, 2000; 271:142–154.
43.
BiglioneM, VidanO, MahieuxR, de ColomboM, de los Angeles de BasualdoM, BonnetM, PankowG, De EfronMA, ZorrillaA, TekaiaF, MurphyE, de TheG, GessainA. Seroepidemiological and molecular studies of human T cell lymphotropic virus type II, subtype b, in isolated groups of Mataco and Toba Indians of northern Argentina. AIDS Res Hum Retroviruses, 1999; 15:407–417.
44.
FujiyoshiT, LiHC, LouH, YashikiS, KarinoS, ZaninovicV, OneeglloSG, CamachoM, AndradeR, HurtadoLV, GomezLH, DamianiE, CartierL, DipierriJE, HayamiM, SonodaS, TajimaK. Characteristic distribution of HTLV type I and HTLV type II carriers among native ethnic groups in South America. AIDS Res Hum Retroviruses, 1999; 15:1235–1239.
45.
BeriniCA, PandoMA, BautistaCT, EirinME, Martinez-PeraltaL, WeissenbacherM, AvilaMM, BiglioneMM. HTLV-1/2 among high-risk groups in Argentina: molecular diagnosis and prevalence of different sexual transmitted infections. J Med Virol, 2007; 79:1914–1920.
46.
BlejerJL, SaguierMC, SalamoneHJ, CarrerasLA. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires]Sangre (Barc), 1995; 40:447–451.
47.
BiglioneM, AvilaMM, BiglioneJ, WeisburdG, LibonattiO, GessainA. [Molecular characterization of HTLV-II from an intravenous drug addict with AIDS in Argentina]Rev Argent Microbiol, 1996; 28:139–142.
48.
PandoMA, De SalvoC, BautistaCT, EyzaguirreL, CarrionG, FeolaM, LadoI, HoffmanM, BiglioneMM, CarrJK, MontanoSM, SanchezJL, WeissenbacherM, AvilaMM. Human immunodeficiency virus and tuberculosis in Argentina: Prevalence, genotypes and risk factors. J Med Microbiol, 2008; 57:190–197.
49.
WeissenbacherM, RossiD, RadulichG, Sosa-EstaniS, VilaM, VivasE, AvilaMM, CuchiP, ReyJ, PeraltaLM. High seroprevalence of bloodborne viruses among street-recruited injection drug users from Buenos Aires, Argentina. Clin Infect Dis, 2003; 37,Suppl 5:S348–352.
50.
HeneineW, KhabbazRF, LalRB, KaplanJE. Sensitive and specific polymerase chain reaction assays for diagnosis of human T-cell lymphotropic virus type I (HTLV-I) and HTLV-II infections in HTLV-I/II-seropositive individuals. J Clin Microbiol, 1992; 30:1605–1607.
51.
TukePW, LutonP, GarsonJA. Differential diagnosis of HTLV-I and HTLV-II infections by restriction enzyme analysis of 'nested' PCR products. J Virol Methods, 1992; 40:163–173.
52.
GessainA, MauclereP, FromentA, BiglioneM, Le HesranJY, TekaiaF, MillanJ, de TheG. Isolation and molecular characterization of a human T-cell lymphotropic virus type II (HTLV-II), subtype B, from a healthy Pygmy living in a remote area of Cameroon: an ancient origin for HTLV-II in Africa. Proc Natl Acad Sci USA, 1995; 92:4041–4045.
53.
Villafruela MateosA, Arruza EchevarríaA, Martín BazacoJ, Azurmendi ArinI, Zabala EgurrolaJA. HTLV infection after renal transplant. Arch Esp Urol, 2005; 58:1064–1068.
54.
YoshidaM, MiyoshiI, HinumaY. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA, 1982; 79:2031–2035.
55.
GascuelO. BIONJ: An improved version of the NJ algorithm based on a simple model of sequence data. Mol Biol Evol, 1997; 14:685–695.
56.
BlackFL. Tracing prehistoric migrations by the viruses they carry: Human T-cell lymphotropic viruses as markers of ethnic relationships. Hum Biol, 1997; 69:467–482.
57.
MauclereP, AfonsoPV, MeertensL, PlancoulaineS, CalattiniS, FromentA, Van BeverenM, de TheG, Quintana-MurciL, MahieuxR, GessainA. HTLV-2B strains, similar to those found in several Amerindian tribes, are endemic in central African Bakola Pygmies. J Infect Dis, 2011; 203:1316–1323.
